Treatment of scedosporiosis with voriconazole: Clinical experience with 107 patients

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1743-1750

  Troke, Peter ^a   Aguirrebengoa, Koldo ^b   Arteaga, Carmen ^c   Ellis, David ^d   Heath, Christopher H ^e   Lutsar, Irja ^f   Rovira, Montserrat ^g   Nguyen, Quoc ^h   Slavin, Monica ⁱ   Chen, Sharon C A ^j  

^a Old Court ^*  (United Kingdom)

^b HOSPITAL DE CRUCES   (Spain)

^c PFIZER INC   (United States)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

^f UNIVERSITY OF TARTU   (Estonia)

^g HOSPITAL CLÍNIC   (Spain)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ PETER MACCALLUM CANCER CENTRE   (Australia)

^j WESTMEAD HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; MICONAZOLE; TERBINAFINE; VORICONAZOLE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BONE INFECTION; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CHEMOPROPHYLAXIS; CHILD; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HALLUCINATION; HEMATOLOGICAL PARAMETERS; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; IN VITRO STUDY; INFECTION PREVENTION; LEUKEMIA RELAPSE; LIVER FUNCTION TEST; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SCEDOSPORIOSIS; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SCEDOSPORIUM PROLIFICANS; SIDE EFFECT; SKIN INFECTION; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; MALE; MIDDLE AGED; PYRIMIDINES; SCEDOSPORIUM; TREATMENT OUTCOME; TRIAZOLES;

EID: 42949088904     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01388-07     Document Type: Article

References (50)

1. Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, and T. J. Walsh on behalf of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14.
2. Berenguer, J., J. L. Rodriguez-Tudela, C. Richard, M. Alvarez, M. A. Sanz, L. Gaztelurrutia, J. Ayats, J. V. Martinez-Suarez, et al. 1997. Deep infections caused by Scedosporium prolificans: a report on 16 cases in Spain and a review of the literature. Medicine (Baltimore) 76:256-265.
3. Bhat, S. V., D. L. Paterson, M. G. Rinaldi, and P. J. Veldkamp. 2007. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand. J. Infect. Dis. 39:87-90.
4. Capilla, J., and J. Guarro. 2004. Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs. Antimicrob. Agents Chemother. 48:4009-4011.
5. Capilla, J., C. Serena, F. J. Pastor, M. Ortoneda, and J. Guarro. 2003. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob. Agents Chemother. 47:3976-3978.
6. Castiglioni, B., D. A. Sutton, M. G. Rinaldi, J. Fung, and S. Kusne. 2002. Pseudallescheria boydii (Anamorph Scedosporium apiospermum): infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine 81:333-348.
7. Charles, P. G. P., and B. R. Speed. 2002. A case of Scedosporium prolificans septic arthritis responding to combined oral voriconazole and terbinafine. Intern. Med. J. 32:A60.
8. Cuenca-Estrella, M., B. Ruiz-Diez, J. V. Martinez-Suarez, A. Monzon, and J. L. Rodriguez-Tudela. 1999. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J. Antimicrob. Chemother. 43:149-151.
9. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed., p. 899-901. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
10. Espinel-Ingroff, A., V. Chaturvedi, A. Fothergill, and M. G. Rinaldi. 2002. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J. Clin. Microbiol. 40:3776-3781.
11. Espinel-Ingroff, A., E. Johnson, H. Hockey, and P. Troke. 2008. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies. J. Antimicrob. Chemother. 61:616-620.
12. Farina, C., E. Gotti, F. Suter, and A. Goglio. 2006. Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature. Transplant. Proc. 38:1333-1335.
13. German, J. W., S. M. Kellie, M. P. Pai, and P. T. Turner. 2004. Treatment of a chronic Scedosporium apiospermum vertebral osteomyelitis. Case report. Neurosurg. Focus 17:E9.
14. Girmenia, C., G. Luzi, M. Monaco, and P. Martino. 1998. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J. Clin. Microbiol. 36:1436-1438.
15. Gosbell, I. B., V. Toumasatos, J. Yong, R. S. Kuo, D. H. Ellis, and R. C. Perrie. 2003. Cure of orthopedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses 46:233-236.
16. Guarro, J., A. S. Kantarcioglu, R. Horre, J. L. Rodriguez-Tudela, M. Cuenca Estrella, J. Berenguer, and G. Sybren De Hoog. 2006. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med. Mycol. 44:295-327.
17. Hariprasad, S. M., W. F. Mieler, E. R. Holz, H. Gao, J. E. Kim, J. Chi, and R. A. Prince. 2004. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch. Ophthalmol. 122:42-47.
18. Herbrecht, R., D. W. Denning, T. F. Patterson, J. E. Bennett, R. E. Greene, J. W. Oestmann, W. V. Kern, K. A. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R. H. Rubin, J. R. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P. H. Chandrasekar, M. R. Hodges, H. T. Schlamm, P. F. Troke, and B. de Pauw. 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347:408-415.
19. Howden, B. P., M. A. Slavin, A. P. Schwarer, and A. M. Mijch. 2003. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafinc. Eur. J. Clin. Microbiol. Infect. Dis. 22:111-113.
20. Husain, S., P. Munoz, G. Forrest, B. D. Alexander, J. Somani, K. Brennan, M. M. Wagener, and N. Singh. 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin. Infect. Dis. 40:89-99.
21. Idigoras, P., E. Perez-Trallero, L. Pineiro, J. Larruskain, M. C. Lopez-Lopategui, N. Rodriguez, and J. M. Gonzalez. 2001. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin. Infect. Dis. 32:E158-E165.
22. Jabado, N., J. L. Casanova, E. Haddad, F. Dulieu, J. C. Fournet, B. Dupont, A. Fischer, C. Hennequin, and S. Blanche. 1998. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin. Infect. Dis. 27:1437-1441.
23. Kanafani, Z. A., Y. Comair, and S. S. Kanj. 2004. Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review. Eur. J. Clin. Microbiol. Infect. Dis. 23:836-840.
24. Lamaris, G. A., G. Chamilos, R. E. Lewis, A. Safdar, I. I. Raad, and D. P. Kontoyiannis. 2006. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin. Infect. Dis. 43:1580-1584.
25. Li, J. Y., T. Y. Yong, D. I. Grove, and P. T. Coates. 2008. Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient. Transpl. Infect. Dis. 10:63-65.
26. Lutsar, I., S. Roffey, and P. Troke. 2003. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin. Infect. Dis. 37:728-732.
27. Maertens, J., K. Lagrou, H. Deweerdt, I. Surmont, G. E. Verhoef, J. Verhaegen, and M. A. Boogaerts. 2000. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients: case report and review. Ann. Hematol. 79:340-344.
28. Maertens, J., I. Raad, G. Petrikkos, M. Boogaerts, D. Selleslag, F. B. Petersen, C. A. Sable, N. A. Kartsonis, A. Ngai, A. Taylor, T. F. Patterson, D. W. Denning, and T. J. Walsh for the Caspofungin Salvage Aspergillosis Study Group. 2004. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin. Infect. Dis. 39:1563-1571.
29. Marco de Lucas, E., P. Sadaba, P. Lastra Garcia-Baron, M. L. Ruiz Delgado, J. Cuevas, R. Salesa, A. Bermudez, A. Gonzalez Mandly, A. Gutierrez, F. Fernandez, F. Marco de Lucas, and C. Diez. 2006. Cerebral scedosporiosis: an emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation. Eur. Radiol. 16:496-502.
30. Meletiadis, J., J. F. Meis, J. W. Mouton, J. L. Rodriquez-Tudela, J. P. Donnelly, and P. E. Verweij. 2002. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob. Agents Chemother. 46:62-68.
31. Mouas, H., I. Lutsar, B. Dupont, O. Fain, R. Herbrecht, F. X. Lescure, and O. Lortholary. 2005. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin. Infect. Dis. 40:1141-1147.
32. Mursch, K., S. Trnovec, H. Ratz, D. Hammer, R. Horre, A. Klinghammer, S. de Hoog, and J. Behnke-Mursch. 2006. Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode. Childs Nerv. Syst. 22:189-192.
33. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of molds: approved standard M38-A. NCCLS, Wayne, PA.
34. Nesky, M. A., E. C. McDougal, and J. E. Peacock, Jr. 2000. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin. Infect. Dis. 31:673-677.
35. Nulens, E., C. Eggink, A. J. Rijs, P. Wesseling, and P. E. Verweij. 2003. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J. Clin. Microbiol. 41:2261-2264.
36. Panackal, A. A., and K. A. Marr. 2004. Scedosporium/ Pseudallescheria infections. Semin. Respir. Crit. Care Med. 25:171-181.
37. Panichpisal, K., K. Nugent, and J. C. Sarria. 2006. Central nervous system pseudallescheriasis after near-drowning. Clin. Neurol. Neurosurg. 108:348-352.
38. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. de la Torre-Cisneros, G. Just-Nubling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
39. Porte, L., S. Khatibi, L. E. Hajj, S. Cassaing, A. Berry, P. Massip, M. D. Linas, J. F. Magnaval, N. Sans, and B. Marchou. 2006. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans. R. Soc. Trop. Med. Hyg. 100:891-894.
40. Poza, G., J. Montoya, C. Redondo, J. Ruiz, N. Vila, J. L. Rodriguez-Tudela, A. Ceron, and E. Simarro. 2000. Meningitis caused by Pseudallescheria boydii treated with voriconazole. Clin. Infect. Dis. 30:981-982.
41. Purkins, L., N. Wood, P. Ghahramani, K. Greenhalgh, M. J. Allen, and D. Kleinermans. 2002. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob. Agents Chemother. 46:2546-2553.
42. Roffey, S. J., S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. Nedderman, D. A. Smith, D. K. Walker, and N. Wood. 2003. The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug Metab. Dispos. 31:731-741.
43. SAS Institute, Inc. 1989. SAS/STAT users guide, version 8.2 ed. SAS Institute, Inc., Cary, NC.
44. Schwartz, S., M. Ruhnke, P. Ribaud, L. Corey, T. Driscoll, O. A. Cornely, U. Schuler, I. Lutsar, P. Troke, and E. Thiel. 2005. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 106:2641-2645.
45. Steinbach, W. J., and J. R. Perfect. 2003. Scedosporium species infections and treatments. J. Chemother. 15:16-27.
46. Steinbach, W. J., W. A. Schell, J. L. Miller, and J. R. Perfect. 2003. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J. Clin. Microbiol. 41:3981-3985.
47. Symoens, F., C. Knoop, M. Schrooyen, O. Denis, M. Estenne, N. Nolard, and F. Jacobs. 2006. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J. Heart Lung Transplant. 25:603-607.
48. Torre-Cisneros, J., A. Gonzalez-Ruiz, M. R. Hodges, and I. Lutsar. 2000. Voriconazole (VORI) for the treatment of S. apiospermum and S. prolificans infection, abstr. 305. 38th Annu. Meet. Infect. Dis. Soc. Am., New Orleans, LA.
49. Walsh, T. J., J. W. Hiemenz, N. L. Seibel, J. R. Perfect, G. Horwith, L. Lee, J. L. Silber, M. J. DiNubile, A. Reboli, E. Bow, J. Lister, and E. J. Anaissie. 1998. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis. 26:1383-1396.
50. Whyte, M., H. Irving, P. O'Regan, M. Nissen, D. Siebert, and R. Labrom. 2005. Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia. Pediatr. Infect. Dis. J. 24:375-377.